Cardiomyology

26 March 2019
Parallel-2
26-AM-Parallel-2 11:00 > 12:30 Cardiomyology Amphi B


11:00 S04-01 High Risk of Fatal and Non-Fatal Venous Thromboembolism in Myotonic Dystrophy > K. Karim WAHBI (Paris, France) 11:30 S04-02 Altered cytoskeleton in cardiac disease caused by nuclear A-type lamins gene mutations > A. Antoine MUCHIR (Paris, France) 12:00 S04-03 The DMD Heart Protection Trial: A double blind randomised, placebo-controlled, multi-centre trial of combined ACE-inhibitor and beta-blocker therapy in preventing the development of cardiomyopathy in genetically characterised males with DMD without echo-detectable left ventricular dysfunction > J. John BOURKE (Newcastle, United Kingdom)

Copyright © key4events - All rights reserved